Invention Grant
![Imidazo[1,2-a]pyrazines as orexin receptor antagonists](/docs/US/2012-03-06/US08129384B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-a]pyrazines as orexin receptor antagonists
- Patent Title (中): 咪唑并[1,2-a]吡嗪作为食欲素受体拮抗剂
-
Application No.: US12576372Application Date: 2009-10-09
-
Publication No.: US08129384B2Publication Date: 2012-03-06
- Inventor: Giuseppe Alvaro , David Amantini , Sandro Belvedere
- Applicant: Giuseppe Alvaro , David Amantini , Sandro Belvedere
- Applicant Address: GB Greenford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Greenford, Middlesex
- Agent Kathryn A. Lutomski; John Lemanowicz
- Main IPC: A61K31/495
- IPC: A61K31/495
![Imidazo[1,2-a]pyrazines as orexin receptor antagonists](/abs-image/US/2012/03/06/US08129384B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to imidazopyrazine substituted piperidine derivatives and their use as pharmaceuticals.
Public/Granted literature
- US20100160345A1 NOVEL COMPOUNDS Public/Granted day:2010-06-24
Information query
